Comprehensive Engineering Target Inventory for Blood Reconstruction, Regenerative Hematology, EV Therapeutics, Synthetic Blood Systems, and Precision Blood Medicine
Program Code: HEMOREGEN-CHAR-006
Division: HEMOREGEN-BLD-100
Parent Program: HEMOREGEN-BLD-CHAR-001
Classification: Blood Engineering and Target Discovery Atlas
Status: Strategic Master Reference Atlas v1.0
⸻
EXECUTIVE SUMMARY
The Blood Cell Engineering Target Atlas establishes the complete inventory of cellular, molecular, communication, regenerative, and systems-level engineering targets within the blood ecosystem.
Within PROJECT HEMOREGEN-721, engineering targets are defined as biological control nodes whose modulation can:
- Restore blood function
- Enhance regeneration
- Improve communication fidelity
- Prevent disease progression
- Enable synthetic blood systems
- Support universal blood reconstruction
This atlas serves as the target-selection framework for all therapeutic, regenerative, diagnostic, EV engineering, and synthetic blood programs.
⸻
SECTION I — UNIVERSAL TARGET CLASSIFICATION SYSTEM
Target Class I
Cellular Identity Targets
Purpose:
Control lineage specification and cellular phenotype.
⸻
Target Class II
Functional Targets
Purpose:
Control biological performance.
⸻
Target Class III
Communication Targets
Purpose:
Control information transfer.
⸻
Target Class IV
Regenerative Targets
Purpose:
Control blood renewal and reconstruction.
⸻
Target Class V
Microenvironment Targets
Purpose:
Control niche integrity.
⸻
Target Class VI
Synthetic Engineering Targets
Purpose:
Enable artificial blood systems.
⸻
SECTION II — ERYTHROID ENGINEERING TARGETS
Engineering Domain
Oxygen Transport Systems
⸻
Target ERT-001
Hemoglobin Optimization
Function:
Oxygen binding and release.
Engineering Applications:
- Improved oxygen delivery
- Synthetic RBC design
⸻
Target ERT-002
RBC Membrane Stability
Function:
Cell longevity.
Engineering Applications:
- Blood storage enhancement
- Universal donor systems
⸻
Target ERT-003
Oxidative Stress Resistance
Function:
Protection against damage.
Engineering Applications:
- Extended circulation time
- Storage resilience
⸻
Target ERT-004
RBC-EV Communication Network
Function:
Hypoxia communication.
Engineering Applications:
- Oxygen sensing platforms
- Diagnostic systems
⸻
SECTION III — PLATELET ENGINEERING TARGETS
Engineering Domain
Hemostasis and Repair
⸻
Target PLT-001
Megakaryocyte Production Control
Function:
Platelet generation.
Applications:
- Platelet manufacturing
⸻
Target PLT-002
Platelet Adhesion Systems
Function:
Injury recognition.
Applications:
- Synthetic platelet development
⸻
Target PLT-003
Platelet EV Cargo Network
Function:
Repair signaling.
Applications:
- Regenerative EV therapeutics
⸻
Target PLT-004
Clot Resolution Programs
Function:
Prevent thrombosis.
Applications:
- Precision hemostasis
⸻
SECTION IV — APC ENGINEERING TARGETS
Engineering Domain
Immune Intelligence
⸻
Target APC-001
Antigen Presentation Machinery
Applications:
- Cancer vaccines
- Infectious disease vaccines
⸻
Target APC-002
Costimulatory Network
Applications:
- Enhanced immune priming
⸻
Target APC-003
APC-EV Cargo Programs
Applications:
- Cell-free vaccination
⸻
Target APC-004
Memory Programming Systems
Applications:
- Long-term immunity
⸻
SECTION V — TREG ENGINEERING TARGETS
Engineering Domain
Immune Homeostasis
⸻
Target TREG-001
FOXP3 Stability Programs
Applications:
- Autoimmune therapy
⸻
Target TREG-002
IL-10 Regulatory Axis
Applications:
- Inflammatory disease control
⸻
Target TREG-003
CTLA-4 Checkpoint Systems
Applications:
- Transplant tolerance
⸻
Target TREG-004
Treg-EV Tolerance Cargo
Applications:
- Tolerogenic therapeutics
⸻
SECTION VI — NK AND CTL ENGINEERING TARGETS
Engineering Domain
Precision Cytotoxicity
⸻
Target NK-001
Target Recognition Systems
Applications:
- Tumor elimination
⸻
Target NK-002
Granzyme Delivery Programs
Applications:
- Cell-free cytotoxic therapeutics
⸻
Target NK-003
NK-EV Cytotoxic Cargo
Applications:
- Precision oncology
⸻
Target CTL-001
Memory Cytotoxic Programs
Applications:
- Durable immune surveillance
⸻
SECTION VII — HEMATOPOIETIC STEM-CELL ENGINEERING TARGETS
Engineering Domain
Blood Reconstruction
⸻
Target HSC-001
Self-Renewal Networks
Applications:
- Stem-cell expansion
⸻
Target HSC-002
Quiescence Control Systems
Applications:
- Long-term regenerative preservation
⸻
Target HSC-003
Differentiation Control Networks
Applications:
- Directed hematopoiesis
⸻
Target HSC-004
Regenerative EV Production
Applications:
- Blood reconstruction
⸻
SECTION VIII — BONE MARROW NICHE ENGINEERING TARGETS
Engineering Domain
Microenvironment Reconstruction
⸻
Target NICHE-001
CXCL12 Retention Axis
Applications:
- Stem-cell maintenance
⸻
Target NICHE-002
SCF Signaling Systems
Applications:
- HSC support
⸻
Target NICHE-003
Perivascular Activation Programs
Applications:
- Emergency hematopoiesis
⸻
Target NICHE-004
MSC Communication Systems
Applications:
- Regenerative support
⸻
SECTION IX — EV ENGINEERING TARGET ATLAS
Engineering Domain
Biological Communication
⸻
Target EV-001
EV Biogenesis Systems
Applications:
- Increased therapeutic EV production
⸻
Target EV-002
Cargo Loading Programs
Applications:
- Precision EV therapeutics
⸻
Target EV-003
Address Code Systems
Applications:
- Organ-targeted delivery
⸻
Target EV-004
Recipient Recognition Systems
Applications:
- Communication precision
⸻
Target EV-005
Synthetic EV Platforms
Applications:
- Artificial communication networks
⸻
SECTION X — SYNTHETIC BLOOD ENGINEERING TARGETS
Engineering Domain
Artificial Blood Systems
⸻
Target SYN-001
Artificial Oxygen Carriers
Applications:
- Blood replacement
⸻
Target SYN-002
Synthetic Platelet Systems
Applications:
- Trauma medicine
⸻
Target SYN-003
Synthetic EV Systems
Applications:
- Cell-free communication
⸻
Target SYN-004
Programmable Blood Modules
Applications:
- Precision medicine
⸻
Target SYN-005
Universal Compatibility Systems
Applications:
- Universal blood products
⸻
SECTION XI — BLOOD FAILURE CORRECTION TARGETS
Engineering Domain
Blood Restoration
⸻
Target REST-001
Communication Restoration
Applications:
- EV network repair
⸻
Target REST-002
Immune Rebalancing
Applications:
- Autoimmune disorders
⸻
Target REST-003
Regenerative Reactivation
Applications:
- Marrow failure
⸻
Target REST-004
Connectome Reintegration
Applications:
- Multi-organ dysfunction
⸻
SECTION XII — TARGET PRIORITIZATION FRAMEWORK
Universal Blood Engineering Priority Score (UBEPS)
Domain A
Biological Importance
0–20
⸻
Domain B
Clinical Impact
0–20
⸻
Domain C
Engineering Feasibility
0–20
⸻
Domain D
Safety Potential
0–20
⸻
Domain E
Platform Scalability
0–20
⸻
Total Score
0–100
⸻
Score | Priority Classification |
90–100 | Tier 1 Strategic Target |
80–89 | Tier 2 High Priority |
70–79 | Tier 3 Development Target |
60–69 | Tier 4 Exploratory Target |
<60 | Future Research Target |
⸻
SECTION XIII — TARGET HIERARCHY FOR PROJECT HEMOREGEN-721
Tier 1 Strategic Targets
- HSC Self-Renewal Networks
- APC Antigen Presentation Machinery
- Treg FOXP3 Stability Programs
- EV Address Code Systems
- EV Cargo Loading Systems
- Universal Compatibility Systems
- Bone Marrow Niche Integrity Systems
⸻
Tier 2 Strategic Targets
- NK Cytotoxic Programs
- Platelet Repair Programs
- RBC Communication Systems
- Regenerative EV Networks
⸻
Tier 3 Strategic Targets
- Synthetic Blood Modules
- Artificial Communication Systems
- Blood Intelligence Networks
⸻
SECTION XIV — HEMOREGEN THERAPEUTIC INTEGRATION MAP
Diagnostic Platforms
Connected Targets:
- EV Cargo Networks
- RBC Communication Systems
- APC Intelligence Systems
⸻
Therapeutic Platforms
Connected Targets:
- APC Programs
- Treg Programs
- NK Programs
⸻
Regenerative Platforms
Connected Targets:
- HSC Programs
- Niche Programs
- Regenerative EV Programs
⸻
Synthetic Blood Platforms
Connected Targets:
- Artificial RBC Programs
- Synthetic Platelet Programs
- Synthetic EV Programs
⸻
Digital Twin Platforms
Connected Targets:
- Blood Communication Networks
- Blood Intelligence Systems
- Connectome Architecture
⸻
TRANSLATIONAL DEVELOPMENT ROADMAP
TARGET-H1
Target Discovery and Validation
⸻
TARGET-H2
Engineering Feasibility Assessment
⸻
TARGET-H3
Preclinical Prioritization
⸻
TARGET-H4
Platform Development
⸻
TARGET-H5
Digital Twin Integration
⸻
TARGET-H6
Clinical Translation
⸻
NEXT DELIVERABLE
HEMOREGEN-CHAR-007 — Universal Cellular Digital Twin Framework
Will establish:
- Blood Digital Twin architecture
- Single-cell simulation systems
- EV communication simulation engines
- Hematopoietic forecasting models
- Blood failure prediction systems
- Regenerative response simulators
- Synthetic blood optimization engines
- Universal Blood Intelligence Network (UBIN)
- AI-guided blood engineering framework